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bS Supporting Information
Liquid chromatography/mass spectrometry (LC/MS) hasbecome the de facto standard as a platform for proteomic
biomarker discovery studies.1,2 In a typical proteomic biomarker
search, samples originate from a tissue biopt or bodyﬂuid
(plasma, urine, cerebrospinal ﬂuid) of two groups: a case group
and a control group.3,4 Currently, the most important methodol-
ogy for ﬁnding systematic diﬀerences between these groups of
samples by means of LC/MS is shotgun proteomics.5,6 This
methodology comprises MS/MS sequencing measurements in
combination with database searching to identify proteins in the
sample, after which the abundances (based on MS signal inten-
sities or spectral counts) of the identiﬁed proteins are compared.
There are intrinsic problems associated with this approach: the
MS/MS sequencing is largely random, and quantitation of
peptides is dependent on their identiﬁcation.
The sequencing problem is immediately obvious from the
term “shotgun”. Although peptide sequencing by MS/MS is
often referred to as data-dependent, this means, in practice, that
only the most intense peptide signals in a certain retention time
range will be selected for sequencing. Thus, many peptides will
not be sequenced at all, and the choice of peptides to be
sequenced is random with respect to the problem under inves-
tigation. Moreover, when multiple samples are considered—
as in a biomarker search—there is no assurance that a protein
that is present in certain samples will actually be detected in all
of them.
On top of the limited number of sequencing events, a general
problem that any MS/MS-based biomarker search strategy faces
is its dependence on peptide identiﬁcations and quantitations.6
Any peptide ion not readily identiﬁed by database searches
(typically about 7080% of the acquired MS/MS spectra after
validation, in our experience) is therefore not quantiﬁed (and is
thus neglected), even when it might be the most signiﬁcant
dissimilarity between sample sets. Alternative strategies for the
identiﬁcation of peptide sequences from fragment ion spectra,
such as computer-assisted de novo sequencing or manual inter-
pretation, might help to alleviate this problem. However, these
methods also have a limited success rate and are extremely time-
and computer-intensive. With the hardware and software cur-
rently available, it is therefore simply impossible to successfully
identify the majority of peptides in a sample, thus presenting an
intrinsic problem for MS/MS-driven quantitation strategies.
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ABSTRACT: The identiﬁcation of diﬀerential patterns in data originating from
combined measurement techniques such as LC/MS is pivotal to proteomics. Although
“shotgun proteomics” has been employed successfully to this end, this method also has
severe drawbacks, because of its dependence on largely untargeted MS/MS sequencing
and databases for statistical analyses. Alternatively, several MS-signal-based (MS/MS-
independent) methods have been published that are mainly based on (univariate)
Student’s t-tests. Here, we present a more robust multivariate alternative employing
linear discriminant analysis. Like the t-test-based methods, it is applied directly to LC/
MS data, instead of using MS/MS measurements. We demonstrate the method on a
number of simulated data sets, as well as on a spike-in LC/MS data set, and show its
superior performance over t-tests.
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For the above-mentioned reasons, there is an incentive for
database-free and MS/MS-free analysis methods that are able to
extract diﬀerential patterns from LC/MS data without the need
for a peptide or protein identiﬁcation step in the search process.7
Several such methods have been described in the literature.810
Commonly, they employ some modiﬁed version of a t-test to
locate diﬀerential patterns in LC/MS data. For perfect data, with
a large number of samples, no noise or intensity changes, and no
misalignments in the chromatographical direction, these methods
perform adequately. Unfortunately, real-life data are far from
perfect: noise is omnipresent, and the requirement for many
samples opposes that of no misalignments due to, for example,
column replacements and variable performance of the ionization
source, liquid chromatograph, and mass spectrometer over time.
In this article, we introduce the concept of moving-window
discriminant analysis (MWDA). This approach uses a com-
bination of principal component analysis (PCA1113) and
linear discriminant analysis (LDA1215), collectively known as
PCALDA1620 to compare complete mass chromatograms or
mass spectra extracted from the LC/MS data rather than single
intensities, as in t-tests. We show that, for perfect data, its
performance is similar to that of multiple t-tests, but it is far
more robust to imperfections, thus outperforming t-tests in
realistic situations. We also apply both methods to a set of
spike-in LC/MS data (the E. coli data set) that will be made
publicly available as a benchmark model for complex samples
with biomarkers.21 We show that MWDA has a much steeper
initial true positive rate than t-tests for these real data as well and
that it is capable of identifying a signiﬁcant number of spiked-in
peptides in the data. We expect the method to be of use in both
current bottom-up (peptide-based) and upcoming top-down
(whole-protein-based) proteomics.22,23
’THEORY
After the typical data processing steps described in the
Supporting Information, an LC/MS sample can be represented
as a matrix. Figure 1 shows matrix representations of sample 1
from the E. coli data set and sample 1 from a small noiseless data
set that was simulated purely for illustrative purposes (the
illustration data set). The columns of both matrices are mass
spectra separated by (elution) time, and their rows are chroma-
tograms distinguished by mass-to-charge (m/z) ratio. Generally,
complete proteomic LC/MS studies consist of several tens of
samples. Stacked on top of each other, their matrix representa-
tions form a three-dimensional array or data cube of dimensions
(number of m/z values) (number of time points) (number
of samples). Figure 2A shows such a data cube of samples 14 of
the illustration data set; the horizontal slices are matrices like the
one in Figure 1 representing the individual LC/MSmeasurements.
Multiple t-Tests. A basic univariate approach for finding
potential biomarkers applies two-sample Student’s t-tests24 to
the intensities of the case and control samples in the vertical
columns (Figure 2C) at all timem/z combinations in the data
cube. Formally, when a set of multiple inferences is considered
simultaneously, a multiple testing correction is indicated to
prevent the null hypotheses from being rejected incorrectly too
often. In the context of biomarker searches, however, it is not so
much the particular p values for the individual hypothesis tests
that are of interest, but rather their order:10 the smallest p value is
most likely to be caused by a true biomarker. Because multiple
testing corrections are one-to-one functions of the input p values,
their order does not change, and the correction can safely be
left out.
Moving-Window Discriminant Analysis. Instead of just
columns, it is also possible to take complete vertical slices from
the data cube (Figure 2A,B). There are two options: slicing along
the retention time axis gives matrices containing chromatograms
(LC matrices, blue slice in Figure 2B), whereas slicing along the
m/z axis results in amatrix of mass spectra (MSmatrices, red slice
in Figure 2B). These matrices are amenable to multivariate
analyses, which are commonly employed for regular one-dimen-
sional spectroscopical or spectrometrical data (e.g., infrared
Figure 1. Images of the matrix representations of (A) the ﬁrst LC/MS measurement of the E. coli data set and (B) the ﬁrst sample from the illustration
data set. Columns are mass spectra; rows are chromatograms. In both panels, the blue chromatogram at the top is the sum of all ion intensities at each
given time point: the total ion current (TIC). The red mass spectra at the right are the total mass spectra. The color scales for the two panels are similar,
but relative to the samples’ intensity distributions. The rectangle in panel A indicates the part of the E. coli samples that was analyzed in this work.
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spectra, NMR spectra, mass spectra, etc.) and chromatographic
data.1620,25
MWDA proper comprises the application of PCALDA (see
the Supporting Information) to the subsequent mean-centered
LC matrices in the data cube. Moving the window along the m/z
axis or along the time axis, MWDA produces a scalar Fisher
quotient F and a discriminant coordinate vector a for each
subsequent matrix (Figure 3). Combined, the Fisher quotients
make up a vector resembling a mass spectrum. Complementary
to the Fisher quotients, the individual discriminant coordi-
nates resemble chromatograms. Taken together, the discrimi-
nant coordinates form a matrix A of dimensions (number ofm/z
values)  (number of time points), that is, resembling a sample
from the original data set.
Potential biomarkers are now expected to be found in A at the
m/z values (rows) speciﬁed by high values of the Fisher quotient
and in the orthogonal time direction (columns) by the highest
peak (absolute value) in the previously speciﬁed row. In the
original samples, disregarding misalignments, the peak of the
biomarker-peptide is located at that same position.
Here, we use the LDA Fisher quotients F to determine
whether an LC matrix contains a biomarker signal. The percen-
tage (of samples) correctly classiﬁed (PCC) in a cross-validation
setting can be used to the same end. As opposed to F, which is on
a continuous scale, the discrete nature of the computationally
intensive PCC can obscure interesting diﬀerences between the
LC matrices for small sample numbers, however. Apart from
optimizing the settings of PCALDA inMWDA, it might also be
worth considering other discriminant methods [e.g., partial least-
squares discriminant analysis (PLS-DA), elastic nets26] in similar
fashion. Regression methods [e.g., PLS, principal component
regression (PCR)] would also be of interest to use in an
analogous approach for data from time series or other settings
that diﬀer from the typical two-class casecontrol setup.
Figure 3. The MWDA procedure applied to LC matrices of the illustration data set: PCALDA is applied to the subsequent LC matrices of the small
simulated data set. Each application results in a discriminant coordinate a (a vector) and a Fisher quotient F (a scalar). Combined, the Fisher quotients
make up a vector fB that can be plotted as a mass-spectrum-like structure, with the intensities representing the classiﬁability of the corresponding LC
matrices. The discrimininant coordinates together make up a matrix A that is similar to the matrix of an LC/MSmeasurement (Figure 1). A high Fisher
quotient means that the corresponding LCmatrix is well-classiﬁable and, thus, is likely to contain one or more chromatographic proﬁles that distinguish
between the sample classes. The proﬁle of interest can be found from the associated discriminant coordinate.
Figure 2. Part of the data cube of the illustration data set. The black horizontal slices in panel A represent the ﬁrst four LC/MS samples of the data set.
The blue vertical slice is an LC matrix, containing chromatograms; the red slice contains mass spectra and thus is an MS matrix. The vertical column in
panel C contains a single intensity per sample. These intensities can be subjected to a t-test, whereas the LC andMSmatrices are amenable tomultivariate
analyses such as LDA.
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’EXPERIMENTAL SECTION
Both simulated and real LC/MS data sets were used in this
work. A short description of both types of data sets follows; more
elaborate information is presented in the Supporting Informa-
tion, including the functions and scripts that were used for
simulating data.
Thirty-two data sets were simulated in R,27 to assess the
relative performances of MWDA and t-tests for diﬀerent
amounts of misalignment. All of these data sets had the same
dimensions (1000  2000  17). The number of samples (17)
and their class distribution (11 from class one, 6 from class two)
were equal to those in the real E. coli data set. All class one
samples in all 32 data sets contained 1000 compounds, char-
acterized by a single Gaussian elution proﬁle, but diﬀerent
numbers (between 1 and 10) of MS peaks. That is, the numbers
of peaks may diﬀer slightly between samples in data sets A and B
but are the same for all samples in data set A. Compared to class
one samples, class two samples contain ﬁve extra compounds that
represent the biomarkers. The peak width along the m/z axis is a
single data point; along the retention time axis, it gradually gets
wider according to standard deviation (sd) = max[1, 1 þ
log10(t)]; that is, the standard deviation for the Gaussian line
shape goes from 1 at t = 0 to 4 at t = 1000.
The parameter of interest in the simulated data is the
misalignment between identical compounds in diﬀerent samples.
To investigate its inﬂuence, the 32 simulations consisted of four
groups (14) of eight data sets (AH) each. Each group was
essentially a copy of the other ones (i.e., the compounds in data
set A of group 2 were exactly the same as those in data set A of
group 1), but the groups diﬀered in one main aspect: In group 1,
identical compounds in all samples were located at the exact same
positions along the elution time axis, whereas in groups 24,
they had a random normal shift with standard deviations of 10,
50, and 100 data points, respectively.
The E. coli set is a real 1801  2000  17 [(number of m/z
values)  (number of time points)  (number of samples)]
proteomics data set that consists of LC/MS measurements of
tryptic digests28 of Escherichia coli protein homogenate. Six of the
17 samples were spiked with bovine carbonic anhydrase. As
opposed to the simulated data sets, there was no ground truth
(i.e., prior knowledge about carbonic anhydrase peptides) avail-
able for this set; MWDA and t-tests results were assessed
afterward, based on two further types of experiments: LC/MS/
MS measurements and direct-infusion nano electrospray ioniza-
tion (here called nanospray ionization, NSI) MS measurements
of tryptically digested carbonic anhydrase only.
Data Analysis. Simulated Sets: MWDA and t-Tests. In princi-
ple, MWDA can be applied to either the LC matrices or the MS
matrices of LC/MS data.Misalignments along the retention-time
(LC) axis inhibit its application to MS matrices, however. Thus,
MWDA was applied to only the LC matrices of each set. The
performance of PCALDA is sensitive to the number of
principal components retained prior to LDA. We therefore
opted to use the first three data sets (AC) out of each group
of eight as a training set to determine a tentative optimum for the
number of principal components to retain. The number of
PCs was then fixed for the subsequent MWDA analyses of the
five sets (DG) with similar characteristics per group (the test
sets). For each set, the 1000 Fisher quotients of the respective LC
matrices were used to determine which matrices to designate as
positives.
For comparison, two-sample, two-sided Student’s t-tests were
applied to the intensities at the 2  106 individual m/ztime
points of each set, using pooled variances. The resulting 2 106 p
values cannot be directly compared to the 1000 F values obtained
by applying MWDA to the LC matrices. Therefore, to enable
comparison with MWDA, the lowest p value out of the 2000 for
each LCmatrix was used to determine if the matrix was a positive
according to the t-tests.
E. coli Benchmark Set: MWDA and t-Tests. After the data
processing steps described in the Supporting Information, the LC
matrices of the real spike-in set were analyzed usingMWDA in two
steps: First, the complete 1801  2000  17 array was analyzed
similarly to the simulated sets. The number of PCs to use could not
be based on a training set with a known ground truth in this case
and was therefore determined as the rounded average of the first
“knees” or “elbows” in the scree plots11 of 10 randomly chosen LC
matrices, resulting in five PCs being retained for every LC matrix.
Assuming equal null distributions forMWDAon all LCmatrices, a
permutation test of 18010 total permutations was performed by
making 10 class permutations per LCmatrix. The significance level
was set at 0.10; that is, only Fisher quotients that were higher than
the 90% lowest Fisher quotients of the permuted data sets were
designated positive. Fifty of 1801 Fisher quotients were larger than
the corresponding threshold. Put differently: 50 of 1801 null
hypotheses of “no difference” were rejected. About half of the
peaks were identified as corresponding to (mþ 1)/z, (mþ 2)/z,
and (m þ 3)/z peaks of isotope patterns of which the mono-
isotopic peak was also identified. These isotope peaks were
retained in the further analysis.
To increase the precision of the 50 m/z values, binning, as
described in the Supporting Info, was performed again, starting all
over from the LC/MS data in mzXML format and making 51 new
bins of width 0.01 Th spanning the range of each original 0.5-Th-
wide bin that was positive in the ﬁrst analysis. The resulting 2550
new chromatographic matrices were subjected to MWDA again,
and for each group of 51 sub-bins, the m/z value of the one with
the highest Fisher quotientwas noted. These 50 precisem/z values
were subsequently used for comparison with the additional LC/
MS/MS and direct NSI MS measurements (i.e., without chroma-
tographic separation) of carbonic anhydrase only.
For the t-tests, a similar procedure was followed: Again, the
complete E. coli array was analyzed similarly to the simulated
sets. Rather than making use of the theoretical t-distribution,
permutation tests were used here as well: the class labels were
permuted 10 times, and after each time, the complete E. coli array
was analyzed, using the permuted class labels. For both the
permuted and original class labels, the lowest p value per
LC matrix was determined, as for the simulated sets. Next, the
positive LC matrices, with p values below the 0.10 signiﬁcance
level were determined, resulting in 85 positives. For these, the
LC/MS data were rebinned and reanalyzed, and the precise
results were again compared with those from the additional
measurements.
Finally, after comparing the performance of MWDA and
t-tests for the E. coli set, we decided to compare the performance
of the t-tests with that of random m/z values, to assess the
baseline level for the procedure. To this end, the entire t-test
procedure was applied to the E. coli set with permuted class
labels. Because a permutation test for permuted data would be
meaningless, an arbitrary number of 72 p values were designated
positive, corresponding to an integer percentage of 4% of the
total number of p values and between the numbers of positives
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for MWDA and t-tests. The rest of the procedure was as
described above for the t-tests on unpermuted data.
’RESULTS
For a comparison of classiﬁers, it is good practice to draw
receiver operating characteristic (ROC) curves. In short, an ROC
curve is a plot of the true positive rate (the fraction of positives
that are true positives) versus the false positive rate (the fraction
of negatives that are false negatives). For a comprehensive
explanation, the reader is referred to the excellent article by
Fawcett.29 A prerequisite for making an ROC curve is thus the
identiﬁcation of both positives and negatives as being true and
false positives and negatives, respectively. Identiﬁcation of the
positives for the E. coli set is already a cumbersome task, but it is
manageable in this particular case because the spiked protein is
known and can bemeasured separately, after which its NSIMS or
LC/MS signals can be compared with those on the limited list of
positives. Identifying and quantifying the number of negatives in
an objective manner is a problem of a diﬀerent order, however,
because it involves many more signals, often of lower quality, and
the number of true and false negatives is very dependent on the
exact criteria that are chosen. Therefore, for ease and objectivity,
instead of ROC curves, we chose to plot the true positive rates
versus the total number of LC matrices designated positive for
the E. coli set, as well as, consequentially, for the simulated sets.
For the latter, the two types of plots are nearly identical, as can be
seen from comparing the ROC curves in the Supporting
Information with the plots in the following sections, and in all
cases discussed in this article, the plots convey the same message,
namely, that the curve that shows the steepest ascent near the
origin represents the best biomarker identiﬁcation method.
Simulated Sets. Figure 4 shows plots of the average percen-
tage of true positives versus the number of LC matrices desig-
nated positive for the training set. The curves were constructed in
a fashion similar to the ROC curves,29 by simply ordering the F or
p values from high to low significance and comparing the
associated LC matrices with the list of LC matrices known to
Figure 4. Average percentage true positive rates for the simulated training sets, using t-tests andMWDA. The shaded blue areas represent the interesting
regions of the plots where up to 10% of the LC matrices were designated positive.
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contain an isotope peak of an added component. Percentages
rather than numbers were used, because the total number of true
positives in each of the eight data sets varied, as components can
have different numbers of isotope peaks. Averages were taken
over the three data sets from each group with similar shifts. Based
on Figure 4, the numbers of principal components retained for
MWDA analyses of the test sets were 5 for the perfectly aligned
set and 10 for the consecutive misaligned sets. The shaded blue
areas are the arbitrary “regions of interest” where up to 10% of
the LC matrices were designated positive. For ROC curves, the
partial area under the curve (pAUC) could be calculated in the
similar region.
Figure 5 shows the results of MWDA analyses of the test sets,
using the numbers of PCs indicated by the training sets. It is clear
that, for the perfect case of no misalignment, t-tests and MWDA
perform likewise. For a small misalignment on the order of the
peak width, the performance of the t-tests is hardly aﬀected, and
the performance of MWDA drops. For stronger misalignments
comparable to the ones observed in the E. coli set, however, the
performance of the t-tests drops rapidly and becomes signiﬁ-
cantly lower than that of MWDA.
E. coli Benchmark Set.MWDA and t-tests were applied to the
E. coli set blind to any ground truth. Subsequently, LC/MS/MS
and direct NSI MS measurements of tryptically digested pure
carbonic anhydrase were performed, and the results were com-
pared with the MWDA and t-tests lists of positives. The final
results of these comparisons are summarized in Table 1.
Two things are immediately clear from this table: (1) Both the
real t-test and MWDA performed substantially better than the
baseline level, given by the application to t-tests in the permuted-
class situation, and (2) MWDA led to much better results than
the t-tests; that is, even despite the much larger number
Figure 5. Average true positive rates for the simulated test sets, using t-tests and MWDA. The numbers of principal components used for MWDA are
based on the results of the training sets. The shaded blue areas represent the interesting regions of the plots where up to 10% of the LC matrices were
designated positive.
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of positives for the t-tests, the number of true positives for
MWDAwas considerably higher. This fact is also clearly visible in
Figure 6, which shows the initial true positive rates for the three
biomarker searches. Conversely, the number of false positives
was much lower for MWDA than for the t-tests. Finally, as is also
clear from Figure 7, most true positives were already identiﬁed by
the relatively simple direct NSI measurement of carbonic anhy-
drase. For MWDA, a number of positive F values clearly stick out
and match with peaks in the mass spectrum. For the t-tests, some
matches can also be observed, and the t-tests on permuted data
do not show obvious matches, as expected. The LC/MS/MS
measurements supply a few additional identiﬁcations.
’DISCUSSION
With respect to the simulated data, the similarity of the
performances of t-tests and MWDA for perfectly aligned data
is not unexpected. A complete LC/MS measurement contains
many correlated features, such as peptides originating from the
same protein or peptides originating from proteins that are part
of the same biochemical pathway. However, these peptides are
far more likely to display diﬀerent retention behaviors and to
have diﬀerent mass-to-charge ratios than identical ones. There-
fore, apart from chance eﬀects and near-perfect correlations
within a peak or isotope pattern, a perfect (i.e., perfectly aligned,
noiseless, etc.) LC/MS data set will show very few correlations in
its individual mass spectra or chromatograms. As Zuber and
Strimmer30 pointed out, for noncorrelated data, LDA reduces to
diagonal discriminant analysis (DDA), for which t-tests provide
the optimally achievable results.30,31
When peaks are shifted, however, a t-test applied at the top of a
peak in sample x will partly or completely miss the corresponding
peak in sample y. Thus, the test “observes” a large variance (top and
baseline), which ultimately obscures any remaining variance from
diﬀerences between case and control samples. PCALDA, on the
other hand, is able to combine variables that are more strongly
correlated within the case and control groups, respectively, than
between the two. Thus, as long as shifts are not overly large and the
number of samples is not exceedingly small, shifted peaks can still
be compared. For a large number of samples, it can be expected that
the performance of the t-tests catches upwithMWDAagain, simply
because of the 1/n1/2 relation in the test statistic.
As mentioned in the Theory section, the importance of the
exact p or F values that are obtained for t-tests or MWDA,
respectively, is limited. Their rank order is of greater importance
here. Therefore, in retrospect, the signiﬁcance levels that we used
to separate LC matrices into positives and negatives were rather
arbitrary. Another reasonable choice could have been to use a
predetermined cutoﬀ for the number of positives, based on
reasonable limits for the number of sequencing events in the
ﬁnal LC/MS/MS measurements used for identiﬁcation pur-
poses. All in all, the choice of a cutoﬀ level should strike a
balance between the work load associated with the identiﬁ-
cation and validation of larger numbers of positives and the need
or wish to ﬁnd more true positives by analyzing increasing
numbers of positives with a decreasing likelihood of being true
positives.
It is an interesting observation that MWDA selects multiple
isotope peaks of the same pattern more often than t-tests. This
increases the conﬁdence that an actual biomarker has been found.
One could argue about whether positives should be deﬁned on
the level of peaks, isotope patterns, peptides (including multiple
charge states, adducts, and intramolecular rearrangements), or
proteins (which is not really an alternative in this case). Here, we
have chosen to present the positives as they are found, without an
additional interpretation step.
Instead of using a ﬁxed number of PCs in MWDA for all LC
matrices, it might seem that optimizing the number of PCs per
LC matrix, using a cross-validation approach for instance, might
enhance the results. This is not the case, however! Generally,
classiﬁcation methods are applied to single matrices, and the
hypothesis is that class information is contained in the matrix.
Optimizing the number of PCs in that case is warranted. For the
LC/MS data discussed here, however, the majority of the LC
matrices are expected to contain no classiﬁcation information.
The eﬀect of optimizing the classiﬁcation performance on each
and every matrix is that the positives get lost in the noise of
negatives (results not shown) that are also optimized to give the
best classiﬁcation result possible. Therefore, choosing an overall
number of PCs based on the discrimination between positive and
negative matrices of the training set is actually the better
approach. In practical situations, where no training set with a
known ground truth is available, such as for the E. coli set, the
optimal number of PCs needs to be chosen in a diﬀerent, but still
unbiased, way. Here, we adopted the frequently used approach of
picking the number of PCs before the ﬁrst elbow or knee in a
scree plot.11 The rounded average number of PCs for 10
Table 1. Results for MWDA and t-Tests Applied to the E. coli
Set
method Pb TPc FPd no. of CA ionse m/z (NSI)f
MWDA 50 44 (88%) 6 (12%) 44 (88%) 41 (82%)
t-tests 85 28 (33%) 57 (67%) 25 (29%) 23 (27%)
t-tests (baselinea) 72 9 (13%) 63 (88%) 8 (11%) 3 (4%)
aData with permuted class labels. bNumber of positives as determined
by each method. cNumber (percentage) of true positives. dNumber
(percentage) of false positives. eTotal number of carbonic anhydrase
peptide ions identiﬁed by LC/MS/MS. fNumber (percentage) of m/z
values for which a peak is identiﬁed in the direct NSI mass spectrum.
Figure 6. Partial true positive rates for MWDA, t-tests, and t-tests with
permuted class labels applied to the E. coli set. Solid lines represent
evaluation based on identiﬁcations by LC/MS; dashed lines are for
evaluation based on direct NSI MS. The dotted gray line presents the
maximally achievable true positive rate, that is, when all LC matrices
designated positive are true positives.
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randomly chosen LC matrices was used for all LC matrices.
Other methods are conceivable, however.
In this work, we applied MWDA to only the LC matrices of
LC/MS data sets. In principle, it is also possible to apply it to the
MS matrices, in which case the F values form a chromatogram-
like structure and the discriminant coordinates resemble mass
spectra. However, in that case, misalignments larger than the
chromatographic peak width along the retention time axis truly
prohibit analysis: Because the shifts are orthogonal to the mass
spectral direction, corresponding peaks will simply not be
present in the same MS matrices anymore.
In principle, it is possible to correct for shifts by using alignment
techniques.3234 When a good alignment is obtained, the results of
both t-tests and MWDA will improve, with MWDA being robust
Figure 7. Direct comparison of (A) the carbonic anhydrase direct NSI mass spectrum, (B) the square roots of MWDA Fisher quotients, (C)ln p for
the t-tests, and (D)ln p for the t-tests on permuted data, obtained for the E. coli data set. The green dashed horizontal lines in panels B and C are the
respective 10% signiﬁcance levels obtained from permutation tests. The similar line in panel D is the 4% cutoﬀ used for the permuted data. Yellow dashed
vertical lines were drawn as a guide to the eye from F/p values that are positives (i.e., above the signiﬁcance level/cutoﬀ).
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over a wider range of (remaining) misalignment. In our experience,
obtaining a good alignment is not trivial, however; although
alignment techniqueswill generally improve the agreement between
retention times, in practice, perfect alignment is never achieved.
Preliminary experiments for the E. coli data show that it is very well
possible for biomarker search results to deteriorate upon use of data
that have been aligned and are well-aligned according to generally
used criteria such as the correlation between samples and visual
inspection. Further investigations in this direction are under way.
Although we have focused on comparing a univariate and a
multivariate technique for the analysis of LC/MS data, it should
bementioned that LC/MS data have an extra level of complexity;
not only are they intrinsically multivariate, but they are also of
multiway nature.35,36 Multiway data need multiway data analysis,
but the more sophisticated multiway methods such as parallel
factor analysis (PARAFAC) and Tucker modeling impose very
strict conditions on the data, which LC/MS data do not fulﬁll.
We have, however, applied averaging and unfolding, two basic
techniques from the ﬁeld of multiway analysis that reduce the
data cube to a single matrix and subsequently applied multi-
variate techniques in the normal fashion. The performances of
these methods were considerably lower than those of both t-tests
andMWDA, and therefore, we did not discuss them further here.
Finally, the MWDA method described here oﬀers not only a
solution for current bottom-up (peptide-based) proteomics but
holds great promise for future top-down (protein-based) proteo-
mics by LC/MS. Current advances in top-down instrumentation
enable routine analysis of intact proteins by LC/MS. Electron-
transfer dissociation (ETD) on these instruments allows for intact
protein identiﬁcation but requiresmanual optimization ofMS/MS
fragmentation settings for each individual protein. This criterion
thus implies a limit to the number of proteins amenable to ETD
analysis and, therefore, depends on methods such as MWDA that
select ions of interest for further identiﬁcation fromMS-level data.
We therefore believe that our current MWDAmethod holds great
potential for application in top-down LC/MS-based proteomics in
contrast to identiﬁcation-driven quantitation strategies.
’CONCLUSIONS
In this article, we have extended the use of amultivariate pattern
recognition technique to complex LC/MS data. We applied the
technique to a number of simulated data sets, as well as to real
spike-in LC/MS data. We showed that the method is inherently
more robust to misalignment imperfections than the commonly
applied t-tests—resulting in signiﬁcantly higher true positive
rates—and that it identiﬁes more biomarkers in a practical setting,
characterized by a relatively low number of samples, misalign-
ments, and noise. The current article is mainly a proof of principle,
and more research to establish the exact application ranges of the
method is warranted. However, given the robustness of the
method to data imperfections, we believe the method to be of
importance for the identiﬁcation of biomarkers in current proteo-
mics studies, as well as in upcoming top-down proteomics and
other LC/MS analyses of complex samples (e.g., metabolomics).
The E. coli set discussed in the current article is part of a larger
set of 59 samples that was measured according to a full factorial
design of two factors (spikes) on three levels (concentrations).
The full benchmark data set will be discussed in another work,21
and the raw data (in mzXML format) will be made publicly
available in an online repository. The binned 1801 2000 17
array used here will be made available in .mat (Matlab, The
Mathworks, Inc., Natick, MA) and .RData (R27) formats.
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